Risk Factors of Vascular Invasion in Patients with Resectable Gastric Cancer
-
摘要:目的
分析可切除胃癌患者的临床病理特征,探讨其发生脉管转移的相关危险因素及对患者预后的影响。
方法回顾性分析接受手术切除的1 077例Ⅰ~Ⅲ期胃癌患者资料,根据是否发生脉管转移分为LVI阳性组(672例)与LVI阴性组(405例)。Logistic单因素和多因素分析患者临床病理特征与LVI的关系。利用生存分析研究Ⅰ期胃癌患者脉管侵犯与生存率之间的关系。
结果单因素分析结果显示,肿瘤大小、分化类型、浸润深度、淋巴结转移、TNM分期、Lauren分型、神经侵犯以及CEA、CA125、CA199的升高是发生脉管侵犯的危险因素(P < 0.05)。多因素分析结果显示,肿瘤分化不良、浸润程度深、有淋巴结转移、侵犯神经、CA724升高是发生脉管侵犯的独立风险因素。有脉管侵犯的Ⅰ期胃癌患者5年生存率明显低于无脉管侵犯的患者,两者差异有统计学意义(P < 0.01)。
结论肿瘤分化不良、浸润程度深、有淋巴结转移、侵犯神经、CA724升高的胃癌患者更容易发生脉管侵犯。对于有可能发生脉管侵犯的Ⅰ期胃癌患者,应采取更积极的治疗手段。
Abstract:ObjectiveTo explore the risk factors for vascular invasion and its influence on prognosis of resectable gastric cancer patients by analyzing the clinicopathological features.
MethodsWe retrospectively analyzed the data of 1077 patients with stage Ⅰ-Ⅲ gastric cancer who underwent surgical resection. According to whether vascular invasion occurred, they were divided into LVI positive group (n=672) and LVI negative group (n=405). Logistic univariate and multivariate analyses were used for the relation between clinical pathological features and LVI. Survival analysis was used to study the relation between vascular invasion and survival rate in patients with stage Ⅰ gastric cancer.
ResultsUnivariate analysis showed that tumor size, type of differentiation, depth of invasion, lymph node metastasis, TNM stage, Lauren classification, nerve invasion and the increase of CEA, CA125 and CA199 were risk factors for vascular invasion (P < 0.05). Multivariate analysis showed that poor differentiation, deep invasion, lymph node metastasis, nerve invasion and elevated CA724 were independent risk factors for vascular invasion. The 5-year survival rate of stage Ⅰ gastric cancer patients with vascular invasion was significantly lower than that without vascular invasion (P < 0.01).
ConclusionGastric cancer patients with poor differentiation, deep invasion, lymph node metastasis, nerve invasion and elevated CA724 are more prone to vascular invasion. Patients with stage I gastric cancer at risk of vascular invasion should be treated more aggressively.
-
Key words:
- Gastric cancer /
- Stage Ⅰ gastric cancer /
- Vascular invasion /
- Risk factors /
- Prognosis
-
Competing interests: The authors declare that they have no competing interests.作者贡献:乔一桓:实验设计、实施,采集分析数据,撰写文章李纪鹏:实验设计、对文章的知识性内容作批评性审阅及指导陈乐、杜正华、郭源:采集及分析数据;支持性贡献
-
表 1 胃癌患者脉管侵犯危险因素的单因素分析结果
Table 1 Univariate analysis of risk factors for vascular invasion in patients with gastric cancer
表 2 Ⅰ~Ⅲ胃癌患者脉管侵犯危险因素的多因素分析结果
Table 2 Multivariate analysis of risk factors for vascular invasion in patients with stage Ⅰ-Ⅲ gastric cancer
-
[1] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424. doi: 10.3322/caac.21492
[2] Mei D, Zhao B, Zhang J, et al. Impact of Lymphovascular Invasion on Survival Outcome in Patients With Gastric Cancer[J]. Am J Clin Pathol, 2020, 153(6): 833-841. doi: 10.1093/ajcp/aqaa021
[3] Sun Z, Wang Z, Zhu G, et al. Advanced gastric cancer with early cancer macroscopic appearance: is it worthy of D2 lymphadenectomy?[J]. Ann Surg Oncol, 2010, 17(5): 1278-1290. doi: 10.1245/s10434-009-0890-x
[4] Du C, Zhou Y, Cai H, et al. Poor prognostic factors in patients with stage Ⅰ gastric cancer according to the seventh edition TNM classification: a comparative analysis of three subgroups[J]. J Surg Oncol, 2012, 105(3): 323-328. doi: 10.1002/jso.22082
[5] Lee A, Chung H. Endoscopic Resection of Undifferentiated-type Early Gastric Cancer[J]. J Gastric Cancer, 2020, 20(4): 345-354. doi: 10.5230/jgc.2020.20.e37
[6] Kim JH, Park SS, Park SH, et al. Clinical significance of immunohistochemically-identified lymphatic and/or blood vessel tumor invasion in gastric cancer[J]. J Surg Res, 2010, 162(2): 177-183. doi: 10.1016/j.jss.2009.07.015
[7] Qian J, Qian Y, Wang J, et al. A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy[J]. Drug Des Devel Ther, 2016, 10: 241-258. http://europepmc.org/articles/PMC4771399/
[8] Gujam FJA, Going JJ, Mohammed ZMA, et al. Immunohistochemical detection improves the prognostic value of lymphatic and blood vessel invasion in primary ductal breast cancer[J]. BMC Cancer, 2014, 14: 676. doi: 10.1186/1471-2407-14-676
[9] Comert GK, Basaran D, Akkoz HE, et al. Blood Vessel Invasion in Endometrial Cancer Is One of the Mechanisms of Spread to the Cervix[J]. Pathol Oncol Res, 2019, 25(4): 1431-1436. doi: 10.1007/s12253-018-0498-1
[10] Samejima J, Yokose T, Ito H, et al. Prognostic significance of blood and lymphatic vessel invasion in pathological stage IA lung adenocarcinoma in the 8th edition of the TNM classification[J]. Lung Cancer, 2019, 137: 144-148. doi: 10.1016/j.lungcan.2019.09.022
[11] 桑温昌, 李兆德, 张晓东, 等. 结直肠癌患者脉管侵犯的危险因素及预后分析[J]. 中华诊断学电子杂志, 2019, 7(3): 203-206. doi: 10.3877/cma.j.issn.2095-655X.2019.03.014 Sang WC, Li ZD, Zhang XD, et al. Analysis of risk factors and prognosis on vascular invasion in patients with colorectal cancer[J]. Zhonghua Zhen Duan Xue Dian Zi Za Zhi, 2019, 7(3): 203-206. doi: 10.3877/cma.j.issn.2095-655X.2019.03.014
[12] Wu L, Liang Y, Zhang C, et al. Prognostic significance of lymphovascular infiltration in overall survival of gastric cancer patients after surgery with curative intent[J]. Chin J Cancer Res, 2019, 31(5): 785-796. doi: 10.21147/j.issn.1000-9604.2019.05.08
[13] Lu J, Dai Y, Xie J, et al. Combination of lymphovascular invasion and the AJCC TNM staging system improves prediction of prognosis in N0 stage gastric cancer: results from a high-volume institution[J]. BMC Cancer, 2019, 19(1): 216. doi: 10.1186/s12885-019-5416-8
[14] Podhajeer OL, Benedetti LG, Girotti MR, et al. The role of the matriceUular protein SPARC in the dynamic interaction between the tumor and the host[J]. Cancer Metastasis Rev, 2008, 27(4): 691-705. doi: 10.1007/s10555-008-9146-7
[15] Du CY, Chen JG, Zhou Y, et al. Impact of lymphatic and/or blood vessel invasion in stage Ⅱ gastric cancer[J]. World J Gastroenterol, 2012, 18(27): 3610-3616. doi: 10.3748/wjg.v18.i27.3610
[16] Kim SM, Lee H, Min BH, et al. A prediction model for lymph node metastasis in early-stage gastric cancer: Toward tailored lymphadenectomy[J]. J Surg Oncol, 2019, 120(4): 670-675.
[17] Huang JY, Xing YN, Wang X, et al. The Prognosis Value of Lymphatic Vessel Invasion in pN0 Gastric Cancer Patients with Insufficient Examined Lymph Nodes[J]. J Gastrointest Surg, 2020, 24(2): 299-306. doi: 10.1007/s11605-018-04101-z
[18] Bu Z, Zheng Z, Li Z, et al. Lymphatic vascular invasion is an independent correlated factor for lymph node metastasis and the prognosis of resectable T2 gastric cancer patients[J]. Tumour Biol, 2013, 34(2): 1005-1012. doi: 10.1007/s13277-012-0637-3
[19] Van Cutsem E, Sagaert X, Topal B, et al. Gastric cancer[J]. Lancet, 2016, 388(10060): 2654-2664. doi: 10.1016/S0140-6736(16)30354-3
[20] Gao S, Cao GH, Ding P, et al. Retrospective evaluation of lymphatic and blood vessel invasion and borrmann types in advanced proximal gastric cancer[J]. World J Gastrointest Oncol, 2019, 11(8): 642-651. doi: 10.4251/wjgo.v11.i8.642
[21] Li P, Ling YH, Zhu CM, et al. Vascular invasion as an independent predictor of poor prognosis in nonmetastatic gastric cancer after curative resection[J]. Int J Clin Exp Pathol, 2015, 8(4): 3910-3918. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466962/pdf/ijcep0008-3910.pdf
[22] Choi Won Hyuk, Kim Min Jeong, Park Jun Ho, et al. Lymphatic Invasion Might Be Considered as an Upstaging Factor in N0 and N1 Gastric Cancer[J]. J Clin Med, 2020, 9(5): 1275. doi: 10.3390/jcm9051275
[23] 杜奕奇, 蔡全才, 廖专, 等. 中国早期胃癌筛查流程专家共识意见(草案2017年, 上海)[J]. 中华消化内镜杂志, 2018, 35(2): 77-83. doi: 10.3760/cma.j.issn.1007-5232.2018.02.001 Du YQ, Cai QC, Liao Z, et al. China experts consensus on the protocol of early gastric cancer screening (2017, Shanghai)[J]. Zhonghua Xiao Hua Nei Jing Za Zhi, 2018, 35(2): 77-83. doi: 10.3760/cma.j.issn.1007-5232.2018.02.001
[24] del Casar JM, Corte MD, Alvarez A, et al. Lymphatic and/or blood vessel invasion in gastric cancer: relationship with clinicopathological parameters, biological factors and prognostic significance[J]. J Cancer Res Clin Oncol, 2008, 134: 153-161. doi: 10.1007/s00432-007-0264-3
[25] 国家卫生健康委员会. 胃癌诊疗规范(2018年版)[J]. 中华消化病与影像杂志(电子版), 2019, 9(3): 118-144. doi: 10.3877/cma.j.issn.2095-2015.2019.03.008 National Health Commission. Guidelines for the diagnosis and treatment of gastric cancer (2018 edition)[J]. Zhonghua Xiao Hua Bing Yu Ying Xiang Za Zhi(Dian Zi Ban), 2019, 9(3): 118-144. doi: 10.3877/cma.j.issn.2095-2015.2019.03.008
[26] Tong J, Sun Z, Wang Z, et al. Early gastric cancer with signet-ring cell histologic type: risk factors of lymph node metastasis and indications of endoscopic surgery[J]. Surgery, 2011, 149(3): 356-363. doi: 10.1016/j.surg.2010.07.006
[27] Du CY, Chen JG, Zhou Y, et al. Impact of lymphatic and/or blood vessel invasion in stage Ⅱ gastric cancer[J]. World J Gastroenterol, 2012, 18(27): 3610-3616. doi: 10.3748/wjg.v18.i27.3610
[28] Li F, Chen Z, Tan B, et al. Influential factors and prognostic analysis of blood vessel invasion in advanced gastric cancer[J]. Pathol Res Pract, 2019, 216(3): 152727. http://d.wanfangdata.com.cn/periodical/95e2ea9365c77b02fe2445cd425e0fef
[29] Wang PL, Huang JY, Zhu Z, et al. Development of a risk-scoring system to evaluate the serosal invasion for macroscopic serosal invasion positive gastric cancer patients[J]. Eur J Surg Oncol, 2018, 44(5): 600-606. doi: 10.1016/j.ejso.2018.01.240
[30] Zhao LY, Chen XL, Wang YG, et al. A new predictive model combined of tumor size, lymph nodes count and lymphovascular invasion for survival prognosis in patients with lymph node-negative gastric cancer[J]. Oncotarget, 2016, 7(44): 72300-72310. doi: 10.18632/oncotarget.11035
[31] Park JH, Ryu MH, Kim HJ, et al. Risk factors for selection of patients at high risk of recurrence or death after complete surgical resection in stageⅠgastric cancer[J]. Gastric Cancer, 2016, 19(1): 226-233. doi: 10.1007/s10120-015-0464-5
-
期刊类型引用(1)
1. 俞文尉, 李琼, 魏晓雪, 桑梓桐, 后雅珺, 刘希胜. MRI多b值DWI定量参数预测胃癌脉管侵犯的价值研究. 磁共振成像. 2025(08) 百度学术
其他类型引用(1)